Sphingosine-1-Phosphate-derived 2-Hexadecenal is a central mediator of ocular neovascularization by inhibiting Sphingosine-1-Phosphate receptor 5. [PDF]
Qian X +16 more
europepmc +1 more source
The Acid sphingomyelinase/ceramide System in Idiopathic Inflammatory Myopathies: a Potential Treatment Target. [PDF]
Chen Y, Yang J, Yin G, Xie Q.
europepmc +1 more source
ASAH2 deficiency affects sphingolipid homeostasis and neuromotor control, causing a progressive neurological disorder. [PDF]
Scala M +10 more
europepmc +1 more source
Insufficient erythrocyte-derived S1P: A pathogenic driver and diagnostic biolipid for tumor progression. [PDF]
Li Z +12 more
europepmc +1 more source
Associations of sphingosine-1-phosphate with soluble P-selectin and adverse clinical outcome in patients with cerebral ischemia with and without acetylsalicylic acid treatment. [PDF]
Gloyer NO +10 more
europepmc +1 more source
Plasma Sphingolipid Profiling Predicts Radiosensitivity in Hepatocellular Carcinoma. [PDF]
Yuan X +8 more
europepmc +1 more source
Computational screening and in vitro evaluation of sphingosine-1-phosphate analogues as therapeutics for Non-Hodgkin's lymphoma. [PDF]
Al Awadh AA.
europepmc +1 more source
Sphingosine kinase 1 (SPHK1); sphingosine 1-phosphate receptor [PDF]
openaire +1 more source
Altered sphingolipid profile in primary biliary cholangitis: associations with fibrosis and inflammation. [PDF]
Rogalska M +9 more
europepmc +1 more source

